ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2318

The Association Between Systemic Lupus Erythematosus (SLE) and Bone Mineral Density (BMD) Polygenic Risk Scores with Lumbar Spine BMD Z-score: A Retrospective Cohort Study

Vrati Mehra1, Daniela Dominguez2, Nicholas Gold2, Andrea Knight2, Deborah Levy2, Fangming Liao2, Eleanor Pullenayegum2, Amer Shammas2, etienne Sochett2, Reza vali2, Declan Webber3, Earl Silverman4 and Linda Hiraki2, 1The Hospital for Sick Children & University of Toronto, Toronto, ON, Canada, 2The Hospital for Sick Children, Toronto, ON, Canada, 3University of Toronto, Mississauga, ON, Canada, 4Silverman, Toronto, ON, Canada

Meeting: ACR Convergence 2023

Keywords: Bone density, genetics, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Childhood-onset systemic lupus erythematosus patients < 18 years (cSLE) are at risk for reduced bone mineral density (BMD) due to disease activity and chronic glucocorticoid exposure. Genetics play a role in SLE susceptibility. Our aim was to assess the genetic contribution to BMD among a multi-ethnic cSLE cohort.

Methods: All patients were diagnosed and followed at the SickKids and had baseline Lumbar Spine (LS) BMD scan, defined as 1 month prior, or up to one year post cSLE diagnosis. The main outcome of interest was LS (L1-L4) BMD z scores. Two weighted polygenic risk scores (PRSs)- 1) BMD PRS 2) SLE PRS were calculated based on largest GWASs to date. Both PRSs were regressed with BMD z-scores in linear models adjusted for demographics, glucocorticoid exposure, height percentile, BMI, and an indicator for lupus nephritis and/or neuropsychiatric lupus.

Results: The study included 284 patients, 82% female, 29% of European, and 28% of East Asian ancestry. The median age of cSLE diagnosis was 13.5 years [IQR 11.1, 15.3]. In multivariate model, a higher BMD PRS was significantly associated with low BMD z-score (β: -0.75; 95%CI: -1.32, -0.18; P=0.01) as was prior steroids use (β: -0.34; 95%CI: -0.63, -0.04; P=0.02). No association was found between SLE PRS and LS BMD z-scores. Height percentile and BMI were significantly associated with BMD z-score, however presence of LN and/or NPSLE was not.

Conclusion: High BMD PRS was significantly associated with lower LS BMD z-score in cSLE patients at baseline. BMD PRS may be an effective tool to stratify cSLE patients.


Disclosures: V. Mehra: None; D. Dominguez: None; N. Gold: None; A. Knight: Pfizer, 6; D. Levy: None; F. Liao: None; E. Pullenayegum: None; A. Shammas: None; e. Sochett: None; R. vali: None; D. Webber: None; E. Silverman: None; L. Hiraki: None.

To cite this abstract in AMA style:

Mehra V, Dominguez D, Gold N, Knight A, Levy D, Liao F, Pullenayegum E, Shammas A, Sochett e, vali R, Webber D, Silverman E, Hiraki L. The Association Between Systemic Lupus Erythematosus (SLE) and Bone Mineral Density (BMD) Polygenic Risk Scores with Lumbar Spine BMD Z-score: A Retrospective Cohort Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/the-association-between-systemic-lupus-erythematosus-sle-and-bone-mineral-density-bmd-polygenic-risk-scores-with-lumbar-spine-bmd-z-score-a-retrospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-between-systemic-lupus-erythematosus-sle-and-bone-mineral-density-bmd-polygenic-risk-scores-with-lumbar-spine-bmd-z-score-a-retrospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology